TW1 <GO>TARGET WATCH2 <GO>MARKETLIVE
API

Devyser

Latest price
54.80 SEK
17/09/2026
Latest (1)
90.00 SEK
+64.23%
Upside
DVYSR
3 mo+64.23%1 price targets
6 mo+64.23%1 price targets
1 yr+131.75%2 price targets
Max 3 price targets
Pareto Securities
HealthcareMedical Devices

About The Company

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Yahoo Finance

Latest Target

The most recently set price target for the stock, from a single analyst.

Target
90.00 SEK
Upside
+64.23%
Latest price54.80 SEK

Consensus

Consensus
150.00 SEK
Upside
+173.72%

Based on older targets - no fresh targets in the last 90 days.

Latest price54.80 SEK

Insider Trades for Devyser

No insider trades for the selected period.

More Price Targets for Devyser

Analyst
Hit rate 54 %
Date
Jul 21
Target
90.00 SEK

Analyst
Hit rate 51 %
Date
Feb 13

Analyst
Hit rate 20 %
Date
Jul -25

Analyst
Hit rate 57 %
Date
Jul -25